You are here: Industry Insights > pDNA

News List

AGC Biologics Supports Omicron-based Vaccine Candidate Manufacturing contractpharma
February 09, 2022
Global CDMO’s Heidelberg facility supplies more pDNA material to help address growing needs.
AGC Biologics Inks Supply Deal for COVID-19 Vaccine contractpharma
June 08, 2021
CDMO’s Heidelberg facility to supply plasmid DNA for Pfizer/BioNTech COVID-19 vaccine.
Catalent Acquires Commercial-Scale Plasmid DNA Mfg. Facility contractpharma
May 08, 2021
Promethera’s Hepatic Cell Therapy Support SA include's 32,400 sq.-ft. facility in Gosselies, Belgium.
Genopis Renamed Wacker Biotech US contractpharma
March 22, 2021
Wacker Biotech US Inc. is the new name of Genopis Inc., the plasmid DNA manufacturer based in San Diego, CA, that Wacker acquired in February. The acquisition concerns a plasmid DNA (pDNA) CDMO site and its associated business.
Maravai Expands CDMO Capabilities Through TriLink Biotechnologies contractpharma
March 16, 2021
Maravai LifeSciences, a global provider of life science reagents and services to researchers and biotech innovators, has expanded its contract development and manufacturing organization (CDMO) capabilities at TriLink BioTechnologies with the launch of ...
Cytovance Biologics Offers Licensing for Plasmid DNA Manufacturing contractpharma
March 10, 2021
The Keystone Expression System pDNA platform is an end-to-end solution for manufacturing GMP pDNA at scale.
Catalent Acquires Delphi Genetics contractpharma
February 24, 2021
Launches US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities.